KAUST researchers introduce deepBlastoid, an AI platform automating and standardizing classification of human blastoids from brightfield images with high accuracy and efficiency.
Key Details
- 1deepBlastoid uses a ResNet-18 architecture to classify human blastoid images in five categories.
- 2The curated dataset includes 17,133 brightfield images, with 2,407 expert-labeled.
- 3Achieved up to 97% accuracy by combining the base model (87%) with a Confidence Rate metric for expert fallback.
- 4Processes 273.6 images per second—1,000 times faster than human experts.
- 5Tool validated in drug dose optimization and safety assessment use cases.
- 6Publicly available tools and dataset support global research customization.
Why It Matters
DeepBlastoid exemplifies the potential of AI-powered image analysis for scalable, objective, and reproducible evaluation in developmental biology—a workflow parallel to emerging radiology and digital pathology automation. Its open-source tools may inspire similar strategies for image-intensive tasks in radiology and pathology.
Source
EurekAlert
Related News
•EurekAlert
AI Model BIOPREVENT Predicts Complications in Stem Cell Transplant Patients
A new AI tool, BIOPREVENT, predicts serious post-transplant complications months before symptoms appear using blood biomarkers and clinical data.
•EurekAlert
New Review Explores Cancer-Inflammation Link and Imaging AI in Precision Therapy
A recent review highlights inflammation’s dual role in cancer progression and how emerging tools like AI and imaging biomarkers are enhancing personalized immunotherapy.
•EurekAlert
CNN-Based AI Enhances Lung Nodule Detection on CT Scans
A CNN-based system achieved high accuracy in detecting and classifying pulmonary nodules using LIDC-IDRI CT data.